Document Detail

Liver Preservation with SCOT 15 Solution Decreases Posttransplantation Cholestasis Compared with University of Wisconsin Solution: A Retrospective Study.
MedLine Citation:
PMID:  22099807     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: SCOT 15 is a new solution to preserve abdominal organs for transplantation. Its principal characteristic is the use of polyethylene glycol. Herein We report our experience using SCOT 15 compared with the reference University of Wisconsin (UW) solution for hepatic transplantation.
METHODS: We compared 2 groups: SCOT 15 (n = 33; 2009-2010) versus UW (n = 34; 2008-2010), which were paired for cold and warm ischemic times, donor ages, and graft weights. Endpoints were biologic tests in the first 2 months after the operation. A linear mixed model was used to evaluate longitudinal changes and influences of each solution.
RESULTS: No primary failure was observed. At postoperative day 0, transaminase values were higher in the SCOT 15 than in the UW group: aspartate transaminase: 2,435 ± 399 vs 589 ± 83 IU/L (P < .01); alanine transaminase: ALT: 1,207 ± 191 vs 484 ± 64 IU/L (P < .05), then returned to low levels in both groups. From day 0 to 8, coagulation factors reached normal values; there was no difference between the 2 groups. Total bilirubin decreased similarly in the 2 groups. However, from the second postoperative week (W1) to W8, the SCOT 15 group showed a slow decrease in the mean values of gamma-glutamyltranspeptidase (gGT) from 233 ± 125 to 130 ± 161 IU/L, which were significantly lower than those in the UW group, where the gGT remained around 300 IU/L (P < .01). The End-Stage Liver Disease, Child-Pugh, or United Network for Organ Sharing scores, primary liver diseases, hepatitic C virus status, arterial or biliary complications, and male/female ratio, which was different in the 2 groups, did not statistically influence these results.
CONCLUSIONS: The main effect of cold storage of human liver using SCOT 15 compared with UW solution was to decrease cholestasis following transplantation.
E Savier; B Granger; F Charlotte; N Cormillot; J M Siksik; J C Vaillant; L Hannoun
Related Documents :
7524777 - Intraoperative anaesthetic management of hypoxaemia during transthoracic endoscopic sym...
22065317 - Budd-chiari syndrome revisited: 38 years' experience with surgical portal decompression.
15803237 - Pulmonary sequestration children: is the thoracoscopic approach a good option?
8493497 - Treatment of primary spontaneous pneumothorax with intrapleural tetracycline instillati...
20303577 - The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscl...
25177377 - Significance of salivary gland radioiodine retention on post-ablation (131)i scintigrap...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  43     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3402-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Service de Chirurgie Digestive et Hépato-Bilio-Pancréatique - Transplantation Hépatique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pancreas preservation for pancreas and islet transplantation: a minireview.
Next Document:  Landmarks in clinical solid organ transplantation in Vietnam.